Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Date 2025 Jan 25

PMID 39858983

Authors

Lin Cheng Han

Henry W C Leung

Heng-Jun Lin

John Hang Leung

Agnes L F Chan

Affiliations

Soon will be listed here.

Abstract

: The relationship between pregnancy complications and the risk of gynecological and breast cancer remains inconclusive, with limited research available. This study aimed to determine whether pregnancy complications, including preeclampsia, gestational diabetes mellitus (GDM), large for gestational age (LGA), or intrauterine growth restriction (IUGR) are associated with the development of endometrial cancer (EC), ovarian cancer (OC), or breast cancer (BC). : This was a population-based case-control study linked to the National Health Insurance Research Database from 2008 to 2020, using ICD codes to identify parous gynecological cases (n = 6714). The propensity score matching method was used to match control groups (n = 1,153,346). Multivariable logistic regression models were used to determine the association between EC, OC, BC risk and pregnancy complications. : In adjusted multivariable logistic regression models, women with a history of preeclampsia did not have a significantly increased risk of endometrial, ovarian, or breast cancer compared to controls. Although women with GDM complications had a significantly increased risk of breast cancer, the increased risk of EC or OC was not significant. The risk of BC in women with a history of IUGR or LGA was not significant, whereas risk statistics for EC or OC in women with a history of IUGR or LGA could not be shown because of the small sample size. : GDM is associated with BC risk. Future studies should aim to determine whether there is a causal relationship. Therefore, cancer screening is warranted in women with GDM.

References

Katsanis W, Shields L, Spinnato J, Gercel-Taylor C, Taylor D . Immune recognition of endometrial tumor antigens induced by multiparity. Gynecol Oncol. 1998; 70(1):33-9. DOI: 10.1006/gyno.1998.4988. View

Main C, Chen X, Zhao M, Chamley L, Chen Q . Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved. Endocrinology. 2022; 163(11). PMC: 9574549. DOI: 10.1210/endocr/bqac141. View

Roy D, Liehr J . Estrogen, DNA damage and mutations. Mutat Res. 1999; 424(1-2):107-15. DOI: 10.1016/s0027-5107(99)00012-3. View

Baud O, Berkane N . Hormonal Changes Associated With Intra-Uterine Growth Restriction: Impact on the Developing Brain and Future Neurodevelopment. Front Endocrinol (Lausanne). 2019; 10:179. PMC: 6443724. DOI: 10.3389/fendo.2019.00179. View

Jordao H, Herink K, Ka E, McVicker L, Kearns C, McMenamin U . Pre-eclampsia during pregnancy and risk of endometrial cancer: a systematic review and meta-analysis. BMC Womens Health. 2023; 23(1):259. PMC: 10182685. DOI: 10.1186/s12905-023-02408-x. View

Pace R, Rahme E, Dasgupta K . Gestational diabetes mellitus and risk of incident primary cancer: A population-based retrospective cohort study. J Diabetes. 2019; 12(1):87-90. DOI: 10.1111/1753-0407.12988. View

Shim S, Noh E, Lee A, Jang E, Kim M, Hwang H . Risk of adverse obstetric outcomes in patients with a history of endometrial cancer: A nationwide population-based cohort study. BJOG. 2023; 130(13):1662-1668. DOI: 10.1111/1471-0528.17553. View

Berkane N, Liere P, Lefevre G, Alfaidy N, Abi Nahed R, Vincent J . Abnormal steroidogenesis and aromatase activity in preeclampsia. Placenta. 2018; 69:40-49. DOI: 10.1016/j.placenta.2018.07.004. View

Lorincz A, Sukumar S . Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006; 13(2):279-92. DOI: 10.1677/erc.1.00729. View

10.

Shields L, Gercel-Taylor C, Yashar C, Wan T, Katsanis W, Spinnato J . Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig. 1997; 4(6):298-304. View

11.

Russo J, Moral R, Balogh G, Mailo D, Russo I . The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005; 7(3):131-42. PMC: 1143568. DOI: 10.1186/bcr1029. View

12.

Ma R, Chan J . Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013; 1281:64-91. PMC: 3708105. DOI: 10.1111/nyas.12098. View

13.

Wan J, Gao Y, Zeng K, Yin Y, Zhao M, Wei J . The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer. Sci Rep. 2016; 6:39744. PMC: 5175126. DOI: 10.1038/srep39744. View

14.

Gill G, Giannakeas V, Read S, Lega I, Shah B, Lipscombe L . Risk of Breast Cancer After Diabetes in Pregnancy: A Population-based Cohort Study. Can J Diabetes. 2023; 48(3):171-178.e1. DOI: 10.1016/j.jcjd.2023.12.007. View

15.

Yang Y, Wu N . Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors. Front Cardiovasc Med. 2022; 9:831297. PMC: 8889031. DOI: 10.3389/fcvm.2022.831297. View

16.

Nechuta S, Paneth N, Velie E . Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control. 2010; 21(7):967-89. PMC: 3863387. DOI: 10.1007/s10552-010-9524-7. View

17.

Chen G, Zeng Q, Tse G . Estrogen and its receptors in cancer. Med Res Rev. 2008; 28(6):954-74. DOI: 10.1002/med.20131. View

18.

Kim J, Chapman-Davis E . Role of progesterone in endometrial cancer. Semin Reprod Med. 2010; 28(1):81-90. PMC: 4767501. DOI: 10.1055/s-0029-1242998. View

19.

Pillay P, Vatish M, Duarte R, Moodley J, Mackraj I . Exosomal microRNA profiling in early and late onset preeclamptic pregnant women reflects pathophysiology. Int J Nanomedicine. 2019; 14:5637-5657. PMC: 6661992. DOI: 10.2147/IJN.S208865. View

20.

Seah J, Sim X, Khoo C, Tai E, van Dam R . Differences in type 2 diabetes risk between East, South, and Southeast Asians living in Singapore: the multi-ethnic cohort. BMJ Open Diabetes Res Care. 2023; 11(4). PMC: 10387644. DOI: 10.1136/bmjdrc-2023-003385. View